Header Logo

Connection

ANITA SABICHI to Patient Compliance

Back to Details
This is a "connection" page, showing publications ANITA SABICHI has written about Patient Compliance.
ANITA SABICHI
Connection Strength
0.073
Patient Compliance
  1. A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer. Cancer Prev Res (Phila). 2011 Oct; 4(10):1580-9.
    View in: PubMed
    Score: 0.073
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.